Annual EBIT
-$78.19 M
-$10.60 M-15.68%
December 31, 2023
Summary
- As of February 7, 2025, DSGN annual earnings before interest & taxes is -$78.19 million, with the most recent change of -$10.60 million (-15.68%) on December 31, 2023.
- During the last 3 years, DSGN annual EBIT has fallen by -$69.86 million (-838.66%).
- DSGN annual EBIT is now -3998.01% below its all-time high of -$1.91 million, reached on December 31, 2019.
Performance
DSGN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$16.25 M
-$1.20 M-8.00%
September 30, 2024
Summary
- As of February 7, 2025, DSGN quarterly earnings before interest & taxes is -$16.25 million, with the most recent change of -$1.20 million (-8.00%) on September 30, 2024.
- Over the past year, DSGN quarterly EBIT has dropped by -$1.20 million (-8.00%).
- DSGN quarterly EBIT is now -2507.70% below its all-time high of -$623.00 thousand, reached on March 31, 2020.
Performance
DSGN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$60.81 M
+$2.58 M+4.06%
September 30, 2024
Summary
- As of February 7, 2025, DSGN TTM earnings before interest & taxes is -$60.81 million, with the most recent change of +$2.58 million (+4.06%) on September 30, 2024.
- Over the past year, DSGN TTM EBIT has increased by +$2.58 million (+4.06%).
- DSGN TTM EBIT is now -9660.83% below its all-time high of -$623.00 thousand, reached on March 31, 2020.
Performance
DSGN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DSGN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.7% | -8.0% | +4.1% |
| 3 y3 years | -838.7% | -43.3% | -112.9% |
| 5 y5 years | -3998.0% | -2507.7% | -9660.8% |
DSGN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -118.2% | at low | -46.0% | +28.1% | -69.7% | +26.6% |
| 5 y | 5-year | -3998.0% | at low | -2507.7% | +28.1% | -9660.8% | +26.6% |
| alltime | all time | -3998.0% | at low | -2507.7% | +28.1% | -9660.8% | +26.6% |
Design Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$16.25 M(+8.0%) | -$60.81 M(-4.1%) |
| Jun 2024 | - | -$15.04 M(+4.5%) | -$63.39 M(-10.6%) |
| Mar 2024 | - | -$14.40 M(-4.8%) | -$70.94 M(-9.3%) |
| Dec 2023 | -$78.19 M(+15.7%) | -$15.12 M(-19.7%) | -$78.19 M(-5.2%) |
| Sep 2023 | - | -$18.82 M(-16.7%) | -$82.46 M(-0.4%) |
| Jun 2023 | - | -$22.60 M(+4.4%) | -$82.83 M(+9.2%) |
| Mar 2023 | - | -$21.65 M(+11.6%) | -$75.87 M(+12.3%) |
| Dec 2022 | -$67.59 M | -$19.39 M(+1.0%) | -$67.59 M(+13.9%) |
| Sep 2022 | - | -$19.19 M(+22.7%) | -$59.33 M(+15.3%) |
| Jun 2022 | - | -$15.64 M(+17.0%) | -$51.47 M(+18.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.37 M(+20.2%) | -$43.52 M(+21.5%) |
| Dec 2021 | -$35.83 M(+330.1%) | -$11.13 M(-1.9%) | -$35.83 M(+25.4%) |
| Sep 2021 | - | -$11.34 M(+47.5%) | -$28.57 M(+45.7%) |
| Jun 2021 | - | -$7.69 M(+35.3%) | -$19.61 M(+46.5%) |
| Mar 2021 | - | -$5.68 M(+47.1%) | -$13.39 M(+60.7%) |
| Dec 2020 | -$8.33 M(+336.6%) | -$3.86 M(+62.0%) | -$8.33 M(+86.4%) |
| Sep 2020 | - | -$2.38 M(+62.9%) | -$4.47 M(+114.2%) |
| Jun 2020 | - | -$1.46 M(+134.8%) | -$2.09 M(+234.8%) |
| Mar 2020 | - | -$623.00 K | -$623.00 K |
| Dec 2019 | -$1.91 M | - | - |
FAQ
- What is Design Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Design Therapeutics?
- What is Design Therapeutics annual EBIT year-on-year change?
- What is Design Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Design Therapeutics?
- What is Design Therapeutics quarterly EBIT year-on-year change?
- What is Design Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Design Therapeutics?
- What is Design Therapeutics TTM EBIT year-on-year change?
What is Design Therapeutics annual earnings before interest & taxes?
The current annual EBIT of DSGN is -$78.19 M
What is the all time high annual EBIT for Design Therapeutics?
Design Therapeutics all-time high annual earnings before interest & taxes is -$1.91 M
What is Design Therapeutics annual EBIT year-on-year change?
Over the past year, DSGN annual earnings before interest & taxes has changed by -$10.60 M (-15.68%)
What is Design Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of DSGN is -$16.25 M
What is the all time high quarterly EBIT for Design Therapeutics?
Design Therapeutics all-time high quarterly earnings before interest & taxes is -$623.00 K
What is Design Therapeutics quarterly EBIT year-on-year change?
Over the past year, DSGN quarterly earnings before interest & taxes has changed by -$1.20 M (-8.00%)
What is Design Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of DSGN is -$60.81 M
What is the all time high TTM EBIT for Design Therapeutics?
Design Therapeutics all-time high TTM earnings before interest & taxes is -$623.00 K
What is Design Therapeutics TTM EBIT year-on-year change?
Over the past year, DSGN TTM earnings before interest & taxes has changed by +$2.58 M (+4.06%)